Gary Leatt, 10% Owner, Director at Acer Therapeutics Inc. (ACER), bought 333,333 shares at $12.00 ($4.0M) on 2017-12-12, disclosed to the SEC on 2018-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 21,271 | $255K | 6.4% |
| 2 | $12.00 | 62,062 | $745K | 18.6% |
| 3 | $12.00 | 250,000 | $3.0M | 75.0% |
| Total | $12.00 avg | 333,333 | $4.0M | 100% |